Description of a Telemedicine Clinic that Materially Advances the Treatment of Human Immunodeficiency Virus-infected Patients

Article Sidebar

31-Mar-6404.pdf
Published Mar 29, 2025
DOI: https://doi.org/10.18103/mra.v13i3.6404

Downloads

Download data is not yet available.

Submit your own article

Register as an author to reserve your spot in the next issue of the Medical Research Archives.

Author Registration

Join the Society

The European Society of Medicine is more than a professional association. We are a community. Our members work in countries across the globe, yet are united by a common goal: to promote health and health equity, around the world.

Join Europe’s leading medical society and discover the many advantages of membership, including free article publication.

Membership

Main Article Content

Stephen A. Klotz
Division of Infectious Diseases, Department of Medicine, University of Arizona, Tucson, AZ
Krystal Fimbres
Division of Infectious Diseases, Department of Medicine, University of Arizona, Tucson, AZ
Melanie Palma Avila
Division of Infectious Diseases, Department of Medicine, University of Arizona, Tucson, AZ
Lawrence D. York
Division of Infectious Diseases, Department of Medicine, University of Arizona, Tucson, AZ

Abstract

Care of patients infected with the Human Immunodeficiency Virus (HIV) in the United States and Europe is mainly outpatient, where treatment is most efficiently provided using Telemedicine. The goal of treatment is the suppression of viral replication, accomplished by placing patients on anti-retroviral therapy early in the process of disease. Viral suppression is then verified by polymerase chain reaction. Anti-retroviral regimens suppress the virus in >95% of patients who adhere to an appropriate regimen. Consequently, the physician’s role in follow up of patients is to encourage adherence to anti-retroviral therapy, a task achievable through Telemedicine clinics. We describe the features of a Telemedicine clinic established in 2006 for residents and incarcerated individuals in the state of Arizona with HIV infection.  Important structural and functional elements of the clinic are presented and discussed. Outcomes of the Telemedicine clinic are compared to those achieved in a traditional Brick-and-Mortar clinics.  The clinic also provides care for individuals desiring Post-Exposure Prophylaxis, and Pre-Exposure Prophylaxis against HIV. This Telemedicine clinic has successfully served the needs of thousands of HIV-infected residents of the state of Arizona.

Keywords: Telemedicine, Human Immunodeficiency Virus (HIV), Anti-retroviral therapy (ART), Viral suppression, Pre-Exposure Prophylaxis (PrEP), Post-Exposure Prophylaxis (PEP), Arizona, Brick-and-Mortar clinics, Patient adherence, Healthcare outcomes

Article Details

How to Cite
KLOTZ, Stephen A. et al. Description of a Telemedicine Clinic that Materially Advances the Treatment of Human Immunodeficiency Virus-infected Patients. Medical Research Archives, [S.l.], v. 13, n. 3, mar. 2025. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/6404>. Date accessed: 09 apr. 2025. doi: https://doi.org/10.18103/mra.v13i3.6404.
ABNT APA BibTeX CBE EndNote - EndNote format (Macintosh & Windows) MLA ProCite - RIS format (Macintosh & Windows) RefWorks Reference Manager - RIS format (Windows only) Turabian
Issue
Vol 13 No 3 (2025): Vol.13, Issue 3, March 2025
Section
Case Reports

The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.

 

References

1. Klotz SA, Chan CB, Bianchi S, Egurrola C, York LD. The Genie Is Out of the Bottle: Telemedicine Is More Effective Than Brick-and-Mortar Clinics in the Care of HIV-Infected Outpatients. Am J Med. 2023 Apr;136(4):360-364. doi: 10.1016/j.amjmed.2022.11.012. Epub 2022 Dec 8. PMID: 36495936; PMCID: PMC9910587.

2. Klotz SA, Jernberg JB, Robbins RA. Turn Healthcare Workers Loose with Outpatient Telemedicine-Let Them Decide Its Fate; No Top-Down Decisions on What It Can and Cannot Do. Am J Med. 2023 Oct;136(10):955-957. doi: 10.1016/j.amjmed.2023.05.005. Epub 2023 May 23. PMID: 37230402; PMCID: PMC10202893.

3. Klotz SA, KR Fimbres, Lawrence D York Commentary. Infectious Diseases Telemedicine and the Arizona Department of Corrections During SARS-CoV-2 Pandemic. Southwest Pulmonary Critical Care Journal. 2023.

4. Ianas V, Berg E, Mohler MJ, Wendel C, Klotz SA. Antiretroviral therapy protects against frailty in HIV-1 infection. J Int Assoc Provid AIDS Care. 2013 Jan-Feb;12(1):62-6. doi: 10.1177/1545109712457241. Epub 2012 Oct 4. PMID: 23042791.

5. Klotz SA, Bradley N, Smith S, Ahmad N. HIV Infection-Associated Frailty: The Solution for Now Is Antiretroviral Drugs: A Perspective. J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958219831045. doi: 10.1177/2325958219831045. PMID: 30803299; PMCID: PMC6748472.

6. Klotz SA, Ahmad N. An Editorial. Aging with Human Immunodeficiency Virus and the impact of long-term antiretroviral therapy. Medical Res Arch 12: no. 9; 2024. doi: https://doi.org/10.18103/mra.v12i9.5703.

7. Klotz, S.A. Phenotypic frailty in people living with HIV is not correlated with age or immunosenescence. International Journal of STD & AIDS https://doi.org/10.1177/09564624221091455

8. Klotz SA, Miller ML, Pogreba-Brown KM, Komatsu KK, Morehouse LM, Dudley SW, Shirazi FM. e-Health for COVID-19 Epidemic: The Arizona Poison and Drug Information Center Experience. Telemed J E Health. 2022 May;28(5):747-751. doi: 10.1089/tmj.2021.0287. Epub 2021 Sep 20. PMID: 34546097.

9. Kouanda A, Faggen A, Bayudan A, Kamal F, Avila P, Arain M, Dai SC, Munroe CA. Impact of Telemedicine on No-Show Rates in an Ambulatory Gastroenterology Practice. Telemed J E Health. 2024 Apr;30(4):1026-1033. doi: 10.1089/tmj.2023.0108. Epub 2023 Oct 26. PMID: 37883629.

10. Young JD, Patel M, Badowski M, Mackesy-Amiti ME, Vaughn P, Shicker L, Puisis M, Ouellet LJ. Improved virologic suppression with HIV subspecialty care in a large prison system using telemedicine: an observational study with historical controls. Clin Infect Dis. 2014 Jul 1;59(1):123-6. doi: 10.1093/cid/ciu222. Epub 2014 Apr 9. PMID: 24723283; PMCID: PMC4305134.

11. Klotz S.A. and York L. Recommendations for routine HIV-1 RNA testing need updating. MedDocs Open Access. Annals of Infectious Diseases and Preventive Medicine. 2023.

12. Walker, D., Moucheraud, C., Butler, D., de Vente, J., Tangonan, K., Shoptaw, S., Currier, J. S., Gladstein, J., & Hoffman, R. (2023). Experiences with telemedicine for HIV care in two federally qualified health centers in Los Angeles: A qualitative study. BMC Health Services Research, 23(1), Article 322. https://doi.org/10.1186/s12913-023-09107-1Y

13. Doshi SD, Charvadeh YK, Seier K, Bange EM, Daly B, Lipitz-Snyderman A, Polubriaginof FCG, Buckley M, Kuperman G, Stetson PD, Schrag D, Morris MJ, Panageas KS. Perspectives on Telemedicine Visits Reported by Patients With Cancer. JAMA Netw Open. 2024 Nov 4;7(11):e2445363. doi: 10.1001/jamanetworkopen.2024.45363. PMID: 39546309; PMCID: PMC11568458.

14. Snoswell CL, De Guzman K, Neil LJ, Isaacs T, Mendis R, Taylor ML, Ryan M. Synchronous telepharmacy models of care for adult outpatients: A systematic review. Res Social Adm Pharm. 2025 Jan;21(1):1-21. doi: 10.1016/j.sapharm.2024.10.005. Epub 2024 Oct 10. PMID: 39472180.

15. Hidalgo-Tenorio C, Martínez-Sanz J. Simplification of antiretroviral therapy: comparative review of two-drug and three-drug regimens in HIV treatment. AIDS Rev. 2025 Feb 17. doi: 10.24875/AIDSRev.M25000081. Epub ahead of print. PMID: 39960818.

16. Lanzafame M, Mori G, Vento S. Advances in HIV Treatment: Long-Acting Antiretrovirals and the Path Toward a Cure. Biomedicines. 2025 Feb 17;13(2):493. doi: 10.3390/biomedicines13020493. PMID: 40002906; PMCID: PMC11853737.